Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Trimetazidine")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 320

  • Page / 13
Export

Selection :

  • and

You are never too oldVITALE, Cristiana.Heart and metabolism. 2007, Num 36, pp 33-37, issn 1566-0338, 5 p.Article

The importance of a metabolic approach to anti-ischemic protectionJACKSON, Graham.Heart and metabolism. 2007, Num 35, pp 22-24, issn 1566-0338, 3 p.Article

Metabolic cardiac protectionGUARINI, Giacinta.Heart and metabolism. 2012, Num 54, pp 25-28, issn 1566-0338, 4 p.Article

Effect of trimetazidine on exercise performance in patients with coronary artery ectasiaDOGAN, Abdullah; OZAYDIN, Mehmet; GEDIKLI, Omer et al.Japanese heart journal. 2003, Vol 44, Num 4, pp 463-470, issn 0021-4868, 8 p.Article

Sensitive and Rapid Method to Determine Trimetazidine in Human Plasma by Liquid Chromatography/Tandem Mass SpectrometryMISTRI, Hiren N; JANGID, Arvind G; SHRIVASTAV, Pranav et al.Journal of AOAC International. 2008, Vol 91, Num 3, pp 562-571, issn 1060-3271, 10 p.Article

Médicaments interagissant avec les mitochondries : effets anti-ischémiques de la trimétazidine = Mitochondria as targets for drugs : effects of trimetazidineSPEDDING, M; TILLEMENT, J. P; MORIN, D et al.Thérapie (Paris). 1999, Vol 54, Num 5, pp 627-635, issn 0040-5957Conference Paper

Metabolic modulation in dilated cardiomyopathyTUUNANEN, Helena; KNUUTI, Juhani.Heart and metabolism. 2010, Num 49, pp 19-22, issn 1566-0338, 4 p.Article

Beneficial effects of Vastarel MR in protecting patients with stable coronary artery disease against early morning ischemic burdenCOQUEMPOT, Stephane.Heart and metabolism. 2009, Num 44, pp 25-28, issn 1566-0338, 4 p.Article

Trimetazidine : Stability indicating RPLC assay methodTHOPPIL, Simmy O; AMIN, P. D.Journal of pharmaceutical and biomedical analysis. 2001, Vol 25, Num 2, pp 191-195, issn 0731-7085Article

Trimetazidine effects on oxidative damageSOON JUN HONG.Heart and metabolism. 2013, Num 60, pp 27-29, issn 1566-0338, 3 p.Article

Cardiomyopathies and heart failureOPIE, Lionel H.Heart and metabolism. 2010, Num 46, pp 17-24, issn 1566-0338, 8 p.Article

Cardioprotective therapy in reperfusion injury: lessons from the European Myocardial Infarction Project - Free Radicals (EMIP-FR)MARZILLI, Mario; HUQI, Alda.Heart and metabolism. 2010, Num 46, pp 35-37, issn 1566-0338, 3 p.Article

Clinical benefits of trimetazidine in diabetic patients with coronary artery diseaseWAFA, Samir S.Heart and metabolism. 2010, Num 48, pp 23-27, issn 1566-0338, 5 p.Article

Effects of trimetazidine on crush injury of the sciatic nerve in rats : A biochemical and stereological studySERARSLAN, Yurdal; BAL, Ramazan; MUHAMMED ENES ALTUG et al.Brain research. 2009, Vol 1247, pp 11-20, issn 0006-8993, 10 p.Article

Quantitative structure-activity relationship analysis of the substituent effects on the binding affinity of derivatives of trimetazidineSLAVOV, Svetoslav; DJUNLIEVA, Maria; ILIEVA, Sonia et al.Arzneimittel-Forschung. 2004, Vol 54, Num 1, pp 9-14, issn 0004-4172, 6 p.Article

Cardioprotective effects of trimetazidine: a reviewMARZILLI, Mario.Current medical research and opinion. 2003, Vol 19, Num 7, pp 661-672, issn 0300-7995, 12 p.Article

Trimétazidine et maladies ischémiques: communications/5ème symposium international sur la Trimétazidine (VASTAREL 20 mg), mars 1987Concours médical (Paris). 1987, Vol 109, Num 36, pp 3442-3528, issn 0010-5309, supplConference Proceedings

Trimetazidine effects on restoring endothelial functionPARK, Kyoung-Ha.Heart and metabolism. 2013, Num 59, pp 25-28, issn 1566-0338, 4 p.Article

Effects of trimetazidine on ventricular function in ischemic cardiomyopathy : A meta-analysis of randomized double-blind placebo-controlled clinical trialsGUTIERREZ, Lerrie; UY, Anjanette; CALATA, Ria Arlina et al.Santo Tomas Journal of Medicine. 2006, Vol 53, Num 2, pp 45-50, issn 0371-3520, 6 p.Article

Metabolic agents in the management of diabetic coronary patients : A new eraCELIK, Turgay; KURSAKLIOGLU, Hurkan; IYISOY, Atila et al.International journal of cardiology. 2008, Vol 127, Num 1, pp 133-134, issn 0167-5273, 2 p.Article

The metabolic approach to improving prognosis in ischemic heart diseaseDI NAPOLI, Pericle.Heart and metabolism. 2007, Num 36, pp 27-31, issn 1566-0338, 5 p.Article

Sensitive and rapid LC-ESI-MS method for the determination of trimetazidine in human plasmaLI DING; BIN GONG; XIAOXIANG CHU et al.Journal of pharmaceutical and biomedical analysis. 2007, Vol 44, Num 2, pp 526-531, issn 0731-7085, 6 p.Article

Quality of life with trimetazidineMARAZZI, Giuseppe; CAMINITI, Giuseppe; VOLTERRANI, Maurizio et al.Heart and metabolism. 2011, Num 52, pp 28-31, issn 1566-0338, 4 p.Article

Effects of Trimetazidine on Endothelial Dysfunction After Sheath Injury of Radial ArteryPARK, Kyoung-Ha; WOO JUNG PARK; KIM, Min-Kyu et al.The American journal of cardiology. 2010, Vol 105, Num 12, pp 1723-1727, issn 0002-9149, 5 p.Article

Role of trimetazidine in management of ischemic cardiomyopathyBERTOMEU-GONZALEZ, Vicente; BOUZAS-MOSQUERA, Alberto; KASKI, Juan Carlos et al.The American journal of cardiology. 2006, Vol 98, Num 5, issn 0002-9149, 19J-24J, SUPConference Paper

  • Page / 13